Those saying CR not needed anytime soon...come on, it's just...

Those saying CR not needed anytime soon...come on, it's just prudent to raise capital after a surge in SP, especially with the market the way it is. Look at IPD, after they jumped from 0.40 to 0.70+ on announcement of rebate code. They did a CR very quickly, and it was very well supported, and at only a slight discount, and it let the instos get on board without playing games with the SP to do so. Since then they've raised heaps more, even though they didn't "need to", and the same with NAN, they raised even though they didn't "need to". Fact is, it's prudent to keep a healthy cash balance, especially for Med tech companies funding R&D, market expansion and regulatory apps